Clinical Trial Update: Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating photodynamic therapy for recurrent, refractory, or second primary head and neck cancer not amenable to surgery or radiation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Quintiles, Inc. | Conditions: Head and Neck Cancer | Phase 2 | Status: UNKNOWN